Top Markets
Coin of the day
LadRx Corporation LadRx Corporation

LadRx Corporation

LADX
株式のランク #42092
LadRx Corporation, a biopharmaceutical company, engages in research and... LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States. The company offers linker activated drug releases (LADR) technology, a platform consists of an organic backbone that is attached to a chemotoxic agent that targets and delivers the chemotoxic agent to the tumor environment and release within the tumor. Its lead candidates comprising LADRs 7, 8, 9, and 10 with novel derivatives of the auristatin and maytansinoid drug targeting tumors; and aldoxorubicin, which is in phase II clinical development for the treatment of pancreatic cancer. In addition, the company develops albumin companion diagnostic (ACDx) to identify patients with cancer that benefits from treatment with the four LADR lead candidates. The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. The company was incorporated in 1985 and is headquartered in Los Angeles, California.
株価
$0.01
最終同期: 2026-07-20
時価総額
$4.95K
変化(1日)
0.00%
変化(1年)
-98.46%
US
取引 LadRx Corporation (LADX)

カテゴリー

LadRx Corporation(LADX)の株価履歴
終値の最高値: $0.01 (2026-07-01)

終値の最安値: $26.67K (1986-11-01)
LadRx Corporation の株価履歴(1986 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 231.61%
2025 -91.99%
2024 -14.48%
2023 -90.49%
2022 -67.61%
2021 -56.35%
2020 313.68%
2019 -41.89%
2018 -74.06%
2017 -31.18%
2016 -83.82%
2015 12.94%
2014 -42.81%
2013 124.10%
2012 -9.68%
2011 -71.09%
2010 -8.10%
2009 239.04%
2008 -89.32%
2007 75.62%
2006 78.27%
2005 -24.70%
2004 -33.08%
2003 685.18%
2002 -56.51%
2001 -29.81%
2000 -57.24%
1999 104.13%
1998 -72.46%
1997 -4.68%
1996 -9.06%
1995 -36.18%
1994 -72.77%
1993 6.07%
1992 0.52%
1991 490.79%
1990 -48.00%
1989 54.10%
1988 -54.86%
1987 88.59%
1986 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.08K -6.92%
KR